home
顺序
主题
题目
日子
96
HLB's acquisition of non-clinical CRO ‘Knotus’, Completed New Drug Development Value Chain
admin
2021.12.27
95
Nanocovax COVID-19 vaccine proven effective
admin
2021.12.20
94
RegeneRx Joint Venture Will Hold Pre-BLA Meeting with FDA on February 28, 2022
admin
2021.12.18
93
Rivoceranib is designated as an orphan drug for liver cancer treatment by the FDA
admin
2021.11.08
92
HLB acquires in vitro diagnostic company
admin
2021.10.28
91
HLB transforming into prominent biopharma company
admin
2021.10.08
90
HLB Group to put Covid-19 vaccine distributor G-TreeBNT under its arms
admin
2021.09.14
89
HLB’s Chinese partner to present efficacy of rivoceranib at ESMO meeting
admin
2021.09.14
88
HLB to present results of rivoceranib at global lung cancer meeting
admin
2021.09.02
87
Hwajin, a subsidiary of HLB, gained the U.S. FDA's approval for Sofjec syringes
admin
2021.08.24